NewcelX (formerly NLS Pharma)
Stans
About NewcelX (formerly NLS Pharma)
NLS Pharma is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia. Its patient-centered approach increases the rate for success and our successful collaboration with experts across industry, academia allows for a target specific and customized approach.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $65.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2026)
- Ticker: nasdaq:NLSP
- Website: nlspharma.com
- Phone: +41 41 618 80 00
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/newcelx-formerly-nls-pharma-573 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.